President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

Pegging drug prices here to those in other countries would yield minimal savings for the United States and devastate funding ...

Inc. , (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L.

The U.S. Department of Health and Human Services (HHS) has announced plans to enforce President Donald J. Trump’s Executive ...